Dr. Kathleen Moore, M.D., MS
Claim this profileUniversity of Oklahoma Health Sciences Center
Expert in Ovarian Cancer
Studies Endometrial Cancer
32 reported clinical trials
83 drugs studied
About Kathleen Moore, M.D., MS
Education:
- Earned an MD from the University of Oklahoma College of Medicine in 1995.
- Obtained an MS in Clinical Research from the University of Oklahoma Health Sciences Center in 2007.
Experience:
- Director of the Gynecologic Oncology Fellowship Program at Stephenson Cancer Center, University of Oklahoma Health Sciences Center.
- Professor in the Department of Obstetrics and Gynecology at the University of Oklahoma Health Sciences Center.
- Renowned gynecologic oncologist and clinical researcher, specializing in ovarian cancer and other gynecologic malignancies.
Area of expertise
1Ovarian Cancer
Global LeaderStage IV
Stage III
BRCA positive
2Endometrial Cancer
Stage IV
MSI-H positive
dMMR positive
Affiliated Hospitals
Clinical Trials Kathleen Moore, M.D., MS is currently running
Zanzalintinib + Paclitaxel
for Uterine Cancer
The purpose of this study is to determine the recommended Phase 2 dose of zanzalintinib when given in combination with paclitaxel in patients with recurrent high-grade uterine cancer. Other objectives include overall safety and tolerability as well as rates of response.
Recruiting1 award Phase 15 criteria
SHetA2
for Gynecologic Cancers
The purpose of this research is to test the safety of the study drug (OK-1) and see what effects (good and bad) this drug has on patients with recurrent solid tumors.
Recruiting1 award Phase 1
More about Kathleen Moore, M.D., MS
Clinical Trial Related1 year of experience running clinical trials · Led 32 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Kathleen Moore, M.D., MS has experience with
- Paclitaxel
- Olaparib
- Carboplatin
- Binimetinib
- Niraparib
- Defactinib
Breakdown of trials Kathleen Moore, M.D., MS has run
Ovarian Cancer
Endometrial Cancer
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kathleen Moore, M.D., MS specialize in?
Kathleen Moore, M.D., MS focuses on Ovarian Cancer and Endometrial Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Kathleen Moore, M.D., MS currently recruiting for clinical trials?
Yes, Kathleen Moore, M.D., MS is currently recruiting for 10 clinical trials in Oklahoma City Oklahoma. If you're interested in participating, you should apply.
Are there any treatments that Kathleen Moore, M.D., MS has studied deeply?
Yes, Kathleen Moore, M.D., MS has studied treatments such as Paclitaxel, Olaparib, Carboplatin.
What is the best way to schedule an appointment with Kathleen Moore, M.D., MS?
Apply for one of the trials that Kathleen Moore, M.D., MS is conducting.
What is the office address of Kathleen Moore, M.D., MS?
The office of Kathleen Moore, M.D., MS is located at: University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104 United States. This is the address for their practice at the University of Oklahoma Health Sciences Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.